presented by Ilene Schwartz
Financial: Ilene Schwartz receives compensation from MedBridge for this course. There is no financial interest beyond the production of this course.
Non-Financial: Ilene Schwartz has no non-financial interests or relationships with MedBridge.
Satisfactory completion requirements: All disciplines must complete learning assessments to be awarded credit, no minimum score required unless otherwise specified within the course.
Ilene Schwartz, PhD, BCBA-D
Dr. Ilene Schwartz is a professor in the Area of Special Education at the University of Washington and the Director of the Haring Center for Research and Training in Education at UW. She earned her Ph.D. in child and developmental psychology from the University of Kansas and is a board certified behavior analyst (BCBA-D). Dr. Schwartz has…Read full bio
1. What is Discrete Trial Teaching?
Discrete trial teaching is often considered the primary building block of behavioral instruction for client with ASD. This chapter will introduce the components of a discrete trial as well as the concept that a discrete trial is an effective strategy for framing instructional interactions across developmental domains. A discrete trial is made up of 5 components:
2. Using Effective Instructions and Prompts
Instructions and prompts are the first two components of a discrete trial. These components provide guidance to clients about what to do and provide support to help them respond in a correct manner. This chapter will review guidelines for using instructions and prompts most effectively.
3. Using Effective Consequences
A consequence is the component of the discrete trial that comes after the client’s response and is contingent on the client’s response. Using appropriate consequences increases the likelihood of the targeted response happening again. This chapter will review guidelines for using consequences most effectively.
4. Using Discrete Trials across Setting
Discrete trials are an effective framework for instruction and can be used to teach new skills across domains and implemented across settings. In this chapter we will review strategies for increasing the use of discrete trials and integrating the use of discrete trials with other therapy approaches.